Edition:
United Kingdom

Albireo Pharma Inc (ALBO.OQ)

ALBO.OQ on NASDAQ Stock Exchange Capital Market

33.00USD
6:28pm BST
Change (% chg)

$0.93 (+2.90%)
Prev Close
$32.07
Open
$32.16
Day's High
$33.00
Day's Low
$31.75
Volume
15,763
Avg. Vol
31,220
52-wk High
$39.67
52-wk Low
$20.27

Consensus Recommendations

Consensus Recommendation Next Earnings (approx.) Company Fiscal Year
End Month
Last Updated
Buy -0.95 December 18 Sep 2018

Analyst Recommendations and Revisions

1-5 Linear Scale Current 1 Month
Ago
2 Month
Ago
3 Month
Ago
(1) BUY 4 4 4 4
(2) OUTPERFORM 3 3 3 3
(3) HOLD 0 0 0 0
(4) UNDERPERFORM 0 0 0 0
(5) SELL 0 0 0 0
No Opinion 0 0 0 0
Mean Rating 1.43 1.43 1.43 1.43

Consensus Estimates Analysis

Sales and Profit Figures in US Dollar (USD)
Earnings and Dividend Figures in US Dollar (USD)
  # of Estimates Mean High Low 1 Year
Ago
SALES (in millions)
Quarter Ending Sep-18 7 0.89 3.00 0.00 0.00
Quarter Ending Dec-18 7 1.27 4.00 0.00 0.10
Year Ending Dec-18 7 14.08 18.93 11.90 4.69
Year Ending Dec-19 7 8.63 26.00 0.00 3.40
Earnings (per share)
Quarter Ending Sep-18 7 -0.95 -0.68 -1.08 -1.03
Quarter Ending Dec-18 7 -0.97 -0.65 -1.17 -1.05
Year Ending Dec-18 7 -3.19 -2.24 -3.70 -3.48
Year Ending Dec-19 7 -3.65 -2.13 -5.54 -3.71

Historical Surprises

Sales and Profit Figures in US Dollar (USD)
Earnings and Dividend Figures in US Dollar (USD)
Estimates vs Actual Estimate Actual Difference Surprise %
SALES (in millions)
Quarter Ending Jun-18 0.57 0.73 0.16 27.76
Quarter Ending Mar-18 31.32 11.20 20.11 64.23
Quarter Ending Dec-17 0.00 0.00 0.00 0.00
Quarter Ending Sep-17 0.00 0.00 0.00 0.00
Quarter Ending Jun-17 0.00 0.00 0.00 0.00

Consensus Estimates Trend

Sales and Profit Figures in US Dollar (USD)
Earnings and Dividend Figures in US Dollar (USD)
  Current 1 Week
Ago
1 Month
Ago
2 Month
Ago
1 Year
Ago
SALES (in millions)
Quarter Ending Sep-18 0.89 0.89 0.82 0.82 0.00
Quarter Ending Dec-18 1.27 1.27 2.00 2.00 0.10
Year Ending Dec-18 14.08 14.08 14.59 14.59 4.69
Year Ending Dec-19 8.63 8.63 10.95 10.95 3.40

Estimates Revisions Summary

  Last Week Last 4 Weeks
Number Of Revisions: Up Down Up Down
Revenue
Quarter Ending Sep-18 0 0 2 1
Quarter Ending Dec-18 0 0 1 2
Year Ending Dec-18 0 0 4 3
Year Ending Dec-19 0 0 1 1
Earnings